FEB 04, 2020 11:12 AM PST

The role of SRR in colorectal cancer

Researchers from Osaka University have recently discovered a new function of the multifunctional enzyme entitled serine racemase (SRR). According to the team’s findings, SRR plays a previously unknown role in cancer metabolism. This finding could lead the way to future anti-cancer treatments that target the enzyme in metabolic pathways.

SRR is already well known to convert L-serine into pyruvate, among other different reactions. And, interestingly, "Pyruvate is known to have an important role in cancer metabolism," explains lead author of the study Dr. Kenji Ohshima. "However, no one had previously studied how pyruvate produced by SRR is involved in cancer metabolism." This got Dr. Ohshima and the other researchers thinking.

In their study, they found that there is a higher presence of SRR in colorectal cancer cells and that cancer cells with more SRR divide faster than other cells. "This was a really exciting discovery because it showed that SRR is involved in colorectal cancer cell proliferation,” elaborates Dr. Ohshima. “When we then looked more closely at the pathway as a whole, we found that pyruvate levels were decreased in a slow-growing SRR mutant colorectal cancer cell line, suggesting that the pyruvate produced by SRR enhances the proliferation of colorectal cancer cells. This result confirmed that the metabolic pathway is integral to the progression of colorectal cancer."

The results from their study were published last month in Nature Metabolism.

Included in the publication were the findings that it was also possible to inhibit the growth of colorectal cancer by disrupting SRR in the metabolic pathway. This simultaneously demonstrated increased efficacy of drugs used to treat cancer and a subsequent reduction in tumors. While this study was conducted in mice models, the researchers are hopeful that their investigations will prove significant for humans.

"There is still work to be done to confirm that our results translate into human cancer systems," explains the senior author of the study Dr. Eiichi Morii. "However, based on these preliminary results, we expect that future strategies targeting SRR will provide effective new therapies for the treatment of colorectal cancer."

Sources: Nature Metabolism, Science Daily

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
AUG 24, 2021
Clinical & Molecular DX
A New Chapter in Metastatic Breast Cancer Biomarkers
AUG 24, 2021
A New Chapter in Metastatic Breast Cancer Biomarkers
For patients diagnosed with metastatic breast cancer, it’s often not the primary tumor that has fatal consequences ...
SEP 20, 2021
Cancer
An Established Ovarian Cancer Antigen Presents a Promising Therapeutic Target
SEP 20, 2021
An Established Ovarian Cancer Antigen Presents a Promising Therapeutic Target
For the past several decades, cancer antigen 125 (CA 125), a protein located on the surface of ovarian cancer cells, has ...
SEP 27, 2021
Cancer
Inflammation Promotes Pancreatic Cancer Progression
SEP 27, 2021
Inflammation Promotes Pancreatic Cancer Progression
Inflammation occurs when the immune response, including immune cells and mediators they produce, protect you from danger ...
DEC 23, 2021
Cancer
Optimizing the Recovery Room Could Help Reduce the Recurrence of Bladder Cancer
DEC 23, 2021
Optimizing the Recovery Room Could Help Reduce the Recurrence of Bladder Cancer
It is estimated that nearly 84,000 people will be diagnosed with bladder cancer in the United States this year ...
DEC 31, 2021
Cell & Molecular Biology
Cells Found to Release Super Small Bioactive Particles Called Supermeres
DEC 31, 2021
Cells Found to Release Super Small Bioactive Particles Called Supermeres
We know that cells are constantly secreting molecules that can have many different biological impacts; the term extracel ...
JAN 20, 2022
Cancer
New Links Between Prostate Cancer Therapy and Depression
JAN 20, 2022
New Links Between Prostate Cancer Therapy and Depression
According to 2021 estimates, prostate cancer will account for more than a quarter of the cancer diagnoses and over 10% o ...
Loading Comments...